Identification of somatic mutations in parathyroid tumors using whole-exome sequencing

MK Cromer, LF Starker, M Choi… - The Journal of …, 2012 - academic.oup.com
Context: The underlying molecular alterations causing sporadic parathyroid adenomas that
drive primary hyperparathyroidism have not been thoroughly defined. Objective: The aim of …

[HTML][HTML] MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases

V Corbo, I Dalai, M Scardoni, S Barbi… - Endocrine-related …, 2010 - erc.bioscientifica.com
Pancreatic endocrine tumors (PETs) may be part of hereditary multiple endocrine neoplasia
type 1 (MEN1) syndrome. While MEN1 gene mutation is the only ascertained genetic …

The tumor suppressor menin regulates hematopoiesis and myeloid transformation by influencing Hox gene expression

YX Chen, J Yan, K Keeshan… - Proceedings of the …, 2006 - National Acad Sciences
Menin is the product of the tumor suppressor gene Men1 that is mutated in the inherited
tumor syndrome multiple endocrine neoplasia type 1 (MEN1). Menin has been shown to …

Genetics of neuroendocrine and carcinoid tumours.

PD Leotlela, A Jauch, H Holtgreve-Grez… - Endocrine-related …, 2003 - erc.bioscientifica.com
Neuroendocrine tumours (NETs) originate in tissues that contain cells derived from the
embryonic neural crest, neuroectoderm and endoderm. Thus, NETs occur at many sites in …

Glucagon‐like peptide 1‐potentiated insulin secretion and proliferation of pancreatic β‐cells GLP‐1促进胰岛素分泌和胰岛β细胞增殖的机制

X Ma, Y Guan, X Hua - Journal of diabetes, 2014 - Wiley Online Library
摘要胰高血糖素样肽‐1 (Glucagon‐like peptide‐1, GLP‐1) 是小肠在进食后分泌的主要的肠促
胰岛素激素, 其主要生物学功能是促进胰岛β 细胞分泌胰岛素. GLP‐1 通过与G‐蛋白偶联受体(G …

Challenges and opportunities in targeting the menin–MLL interaction

T Cierpicki, J Grembecka - Future medicinal chemistry, 2014 - Taylor & Francis
Menin is an essential co-factor of oncogenic MLL fusion proteins and the menin–MLL
interaction is critical for development of acute leukemia in vivo. Targeting the menin–MLL …

[HTML][HTML] The future: genetics advances in MEN1 therapeutic approaches and management strategies

SK Agarwal - Endocrine-related cancer, 2017 - ncbi.nlm.nih.gov
The identification of the multiple endocrine neoplasia type 1 (MEN1) gene in 1997 has
shown that germline heterozygous mutations in the MEN1 gene located on chromosome …

Menin, a tumor suppressor, represses JunD-mediated transcriptional activity by association with an mSin3A-histone deacetylase complex

H Kim, JE Lee, EJ Cho, JO Liu, HD Youn - Cancer research, 2003 - AACR
Menin, a gene product of multiple endocrine neoplasia type I (MEN1), is known to act as a
tumor suppressor to repress JunD transcription factor. However, the mechanism by which …

Menin associates with FANCD2, a protein involved in repair of DNA damage

S Jin, H Mao, RW Schnepp, SM Sykes, AC Silva… - Cancer research, 2003 - AACR
Multiple endocrine neoplasia type I (MEN1) is an inherited tumor syndrome characterized by
tumors in multiple endocrine organs including the parathyroids, pancreatic islets, and the …

[HTML][HTML] Genetics of multiple endocrine neoplasia type 1 syndrome: what's new and what's old

A Falchetti - F1000Research, 2017 - ncbi.nlm.nih.gov
Despite its identification in 1997, the functions of the MEN1 gene—the main gene underlying
multiple endocrine neoplasia type 1 syndrome—are not yet fully understood. In addition …